Fluicell

15/03/2021

We are very proud to present Biozone 6, Fluicell’s new innovation for single-cell pharmacology that lets you perform drug testing and dose-response analysis directly on individual cells, using up to six different compounds or concentration levels. The flexible free-standing design, paired with an intuitive user interface, lets you readily integrate Biozone 6 into your research workflow.
Check it out: https://fluicell.com/biozone-6/

01/03/2021

On March 15, we are launching Biozone 6, the next level in high precision single-cell pharmacology. Biozone 6 allows researchers to perform dose-response studies directly on individual cells and is designed to meet the high quality demands set by pharmaceutical research. To learn more, connect with us already today to schedule a demo: https://fluicell.com/biozone-6-2/

19/02/2021

Did you miss the live webinar with our CTO Gavin Jeffries on single-cell microenvironment engineering using Biopixlar? Don’t worry, you can now watch the entire symposium on our YouTube channel: https://youtu.be/V8CdxPNdMZg

Recording of a live webinar that was held on February 11, 2021. The webinar was organized in collaboration with the Tissue and Cell Engineering Society and S...

12/01/2021

How can bioprinting be used to control the microenvironment around cells in biological tissues? In a live webinar on February 11, Fluicell CTO Dr. Gavin Jeffries will discuss how tissue patterning with single-cell resolution using the Biopixlar bioprinting platform enables researchers to reproduce the complex cellular architecture in actual organs and tissues.

The webinar is part of a seminar series hosted by the Tissue and Cell Engineering Society and is co organized by Swift Analytical Ltd.

Register here: https://us02web.zoom.us/webinar/register/7216075255929/WN_Bn8H0C9KRkWNTHekK5IBwA

22/12/2020

Fluicell is a diverse team representing nationalities from all across the world. Our breadth of backgrounds and experiences is part of what makes us dynamic and innovative. Today, we would like to extend our warmest season’s greeting and wish for all of you a happy and safe 2021.

We would like to express our gratitude to everyone who has been supporting us during the year. To customers using our products, pushing us to always be better. To investors supporting the company towards realizing our goals. To distributors and collaborators for the work that we have done together during the year and that we will continue to do in the year to come.

15/12/2020

2020 has been a year like no other. In the December issue of the CEO Newsletter, Victoire Viannay reflects back on the year that has past and provides a few glimpses of what is to come in 2021. Read the full newsletter here: https://fluicell.com/fluicell-ceo-newsletter/

10/12/2020

In case you missed Victoire Viannay's talk at Investerarjakten Live this Tuesday, you can now watch the whole presentation here and learn about Fluicell's vision to transform research and therapeutics from a single-cell perspective:

01/12/2020

Early next year, we will release Biozone 6 - a new concept in high-resolution single-cell pharmacology. The product has been developed in response to an unmet need for research tools for drug testing and safety pharmacology targeting individual cells.

Read more about Biozone 6 on out site and stay tuned for further news:https://fluicell.com/biozone_6_launches_2021/

12/11/2020

We are very excited to bring you this mini-symposium on single-cell perspectives in cell signaling, which we are organizing on November 25, 16-18 CET, together with npi electronic GmbH.

The symposium will feature talks by scientists who are all prominent researchers within their fields and who will all provide new valuable insights in the area of single-cell signaling.

Register today:

Cell signaling is a ubiquitous process that involves a wide range of highly diverse biological systems, such as ion channels and G protein-coupled receptors. Signaling pathways are also important pharmacological targets due to their involvement in a large number of disease-related processes and symp...

11/11/2020

Biopixlar’s ability to handle even the most sensitive types of cells makes it uniquely positioned for neuron bioprinting. In this article, BioStock explores the need for better in vitro neuronal models and the potential for neuron bioprinting to provide new and important knowledge in the growing area of neurological disorders.

Neurodegenerative diseases are a rapidly growing concern with an increasingly aging population. Decades of research have made it possible to generate neuronal cell cultures in a lab to study their behaviour in disease or injury models or for drug testing. However, these man-made cells lack the compl...

03/11/2020

Join us on November 20 for a live webinar with Dr. Matija Roinik on high-resolution 3D bioprinting of tissue and disease models. In the webinar, which is co-hosted by Swift Analytical, you will learn how Biopixlar enables you to create biological tissues with single-cell precision.
Register here today: https://us02web.zoom.us/webinar/register/WN_3caYzebGRXabvEEi8ngEzA

14/10/2020

Using BioPen, Veronica Jove at The Rockefeller University was able to expose individual mosquito stylets to human blood, thereby allowing her to study the neurobiological mechanisms behind blood-feeding.

This amazing work, lead by Prof. Leslie B. Vosshall, has just been published in the scientific journal Neuron. Our warmest congratulations to everyone in the research group. We are very excited to see what challenges they will take on next.

Read more the work here: https://fluicell.com/mosquito_news/